This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. (MRNA) slid 3.19% to $119.69 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.60% to 10,802.92 and Dow Jones Industrial Average falling 1.11% to 29,260.81. This was the stock's fourth consecutive day of losses. Moderna Inc. closed $314.31 below its 52-week high ($434.00), which the company reached on September 27th.
The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc. (ABBV) fell 1.29% to $141.21, Amgen Inc. (AMGN) fell 0.04% to $226.87, and AstraZeneca PLC ADR (AZN.LN) fell 2.86% to $53.02. Trading volume (3.7 M) remained 974,092 below its 50-day average volume of 4.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 26, 2022.
(END) Dow Jones Newswires
September 26, 2022 16:32 ET (20:32 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.